<?xml version="1.0" encoding="iso-8859-1"?>
<rss xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd" version="2.0">
<channel>
<title>JNCI, Oxford Journals</title>
<link>http://jnci.oxfordjournals.org/</link>
<language>en-uk</language>
<copyright>Oxford University Press</copyright>
<itunes:subtitle>JNCI podcast from Oxford Journals</itunes:subtitle>
<itunes:author>Oxford University Press</itunes:author>
<itunes:summary>A podcast from one of the world's top cancer journals that includes highlights from the current issue and an in-depth interview with a research expert on an important topic of the day</itunes:summary>

<description>A podcast from one of the world's top cancer journals that includes highlights from the current issue and an in-depth interview with a research expert on an important topic of the day</description>
<itunes:owner>
<itunes:name>Oxford University Press</itunes:name>
<itunes:email>jnls.eprod@oxfordjournals.org</itunes:email>
</itunes:owner>
<itunes:image href="http://www.oxfordjournals.org/podcasts/jnci_podcast.jpg"/>
<image>
			<title>JNCI, Oxford Journals</title>
			<url>http://www.oxfordjournals.org/podcasts/jnci_podcast.jpg</url>
			<link>http://www.oxfordjournals.org/our_journals/jnci/podcast.html</link>

		</image>
<itunes:category text="Science &amp; Medicine">
<itunes:category text="Medicine"/>
</itunes:category>
<itunes:explicit>clean</itunes:explicit>
<item>
<title>News Summaries for Volume 104 Issue 11</title>
<itunes:author>Oxford University Press</itunes:author>
<description><![CDATA[: Listen to summaries of the studies and news stories from Issue 11.]]></description>
<enclosure url="http://www.oxfordjournals.org/podcasts/jnci_104.11.summaries.mp3" length="7110656" type="audio/mpeg"/>
<guid>http://www.oxfordjournals.org/podcasts/jnci_104.11.summaries.mp3</guid>
<pubDate>FRI, 13 APR 2012 10:00:00 GMT</pubDate>
<itunes:duration>8:43</itunes:duration>
<itunes:keywords/>
</item>
<item>
<title>News Summaries for Volume 104 Issue 10</title>
<itunes:author>Oxford University Press</itunes:author>
<description><![CDATA[: Listen to summaries of the studies and news stories from Issue 10.]]></description>
<enclosure url="http://www.oxfordjournals.org/podcasts/jnci_104.10.summaries.mp3" length="7110656" type="audio/mpeg"/>
<guid>http://www.oxfordjournals.org/podcasts/jnci_104.10.summaries.mp3</guid>
<pubDate>FRI, 13 APR 2012 10:00:00 GMT</pubDate>
<itunes:duration>8:43</itunes:duration>
<itunes:keywords/>
</item>
<item>
<title>News Summaries for Volume 104 Issue 9</title>
<itunes:author>Oxford University Press</itunes:author>
<description><![CDATA[: Listen to summaries of the studies and news stories from Issue 9.]]></description>
<enclosure url="http://www.oxfordjournals.org/podcasts/jnci_104.9.summaries.wav" length="7110656" type="audio/mpeg"/>
<guid>http://www.oxfordjournals.org/podcasts/jnci_104.9.summaries.wav</guid>
<pubDate>FRI, 13 APR 2012 10:00:00 GMT</pubDate>
<itunes:duration>8:43</itunes:duration>
<itunes:keywords/>
</item>
<item>
<title>The Efficacy of Cancer Vaccines</title>
<itunes:author>Oxford University Press</itunes:author>
<description><![CDATA[: Dr. Jeffrey Schlom talks about therapeutic cancer vaccines]]></description>
<enclosure url="http://www.oxfordjournals.org/podcasts/jnci_104.8.schlom.wav" length="7110656" type="audio/mpeg"/>
<guid>http://www.oxfordjournals.org/podcasts/jnci_104.8.schlom.wav</guid>
<pubDate>FRI, 13 APR 2012 10:00:00 GMT</pubDate>
<itunes:duration>10:53</itunes:duration>
<itunes:keywords/>
</item>
<item>
<title>News Summaries for Volume 104 Issue 8</title>
<itunes:author>Oxford University Press</itunes:author>
<description><![CDATA[: Listen to summaries of the studies and news stories from Issue 8.]]></description>
<enclosure url="http://www.oxfordjournals.org/podcasts/jnci_104.8.summaries.wav" length="7110656" type="audio/mpeg"/>
<guid>http://www.oxfordjournals.org/podcasts/jnci_104.8.summaries.wav</guid>
<pubDate>THU, 04 APR 2012 10:00:00 GMT</pubDate>
<itunes:duration>8:10</itunes:duration>
<itunes:keywords/>
</item>
<item>
<title>News Summaries for Volume 104 Issue 7</title>
<itunes:author>Oxford University Press</itunes:author>
<description><![CDATA[: Listen to summaries of the studies and news stories from Issue 7.]]></description>
<enclosure url="http://www.oxfordjournals.org/podcasts/jnci_104.7.summaries.wav" length="7110656" type="audio/mpeg"/>
<guid>http://www.oxfordjournals.org/podcasts/jnci_104.7.summaries.wav</guid>
<pubDate>THU, 22 MAR 2012 10:00:00 GMT</pubDate>
<itunes:duration>12:38</itunes:duration>
<itunes:keywords/>
</item>
<item>
<title>The Health Effects of E-Cigarettes</title>
<itunes:author>Oxford University Press</itunes:author>
<description><![CDATA[: Dr. Jonathan Winikoff Discusses the Health Effects of E-Cigarettes]]></description>
<enclosure url="http://www.oxfordjournals.org/podcasts/jnci_104.noissue.winikoff.wav" length="7110656" type="audio/mpeg"/>
<guid>http://www.oxfordjournals.org/podcasts/jnci_104.noissue.winikoff.wav</guid>
<pubDate>WED, 14 MAR 2012 10:00:00 GMT</pubDate>
<itunes:duration>11:00</itunes:duration>
<itunes:keywords/>
</item>
<item>
<title>News Summaries for Volume 104 Issue 6</title>
<itunes:author>Oxford University Press</itunes:author>
<description><![CDATA[: Listen to the summaries from Issue 6.]]></description>
<enclosure url="http://www.oxfordjournals.org/podcasts/jnci_104.6.summary.wav" length="7110656" type="audio/mpeg"/>
<guid>http://www.oxfordjournals.org/podcasts/jnci_104.6.summary.wav</guid>
<pubDate>THU, 01 MAR 2012 10:00:00 GMT</pubDate>
<itunes:duration>9:55</itunes:duration>
<itunes:keywords/>
</item>
<item>
<title>News Summaries for Volume 104 Issue 5</title>
<itunes:author>Oxford University Press</itunes:author>
<description><![CDATA[: Listen to the summaries from Issue 5.]]></description>
<enclosure url="http://www.oxfordjournals.org/podcasts/jnci_104.5.summary.wav" length="7110656" type="audio/mpeg"/>
<guid>http://www.oxfordjournals.org/podcasts/jnci_104.5.summary.wav</guid>
<pubDate>WED, 08 FEB 2012 10:00:00 GMT</pubDate>
<itunes:duration>9:44</itunes:duration>
<itunes:keywords/>
</item>
<item>
<title>Efficacy of Smoking Quitlines in Asians</title>
<itunes:author>Oxford University Press</itunes:author>
<description><![CDATA[: Dr. Tony Alberg discusses the efficacy of smoking quitlines in Asians.]]></description>
<enclosure url="http://www.oxfordjournals.org/podcasts/jnci_104.4.alberg.wav" length="7110656" type="audio/mpeg"/>
<guid>http://www.oxfordjournals.org/podcasts/jnci_104.4.alberg.wav</guid>
<pubDate>SAT, 25 JAN 2012 10:00:00 GMT</pubDate>
<itunes:duration>10:23</itunes:duration>
<itunes:keywords/>
</item>
<item>
<title>News Summaries for Volume 104 Issue 4</title>
<itunes:author>Oxford University Press</itunes:author>
<description><![CDATA[: Summaries of the News Stories from JNCI Volume 104 Issue 4.]]></description>
<enclosure url="http://www.oxfordjournals.org/podcasts/jnci_104.4.summary.wav" length="7110656" type="audio/mpeg"/>
<guid>http://www.oxfordjournals.org/podcasts/jnci_104.4.summary.wav</guid>
<pubDate>WED, 01 FEB 2012 10:00:00 GMT</pubDate>
<itunes:duration>9:05</itunes:duration>
<itunes:keywords/>
</item>
<item>
<title>News Summaries for Volume 104 Issue 3</title>
<itunes:author>Oxford University Press</itunes:author>
<description><![CDATA[: Summaries of the News Stories from JNCI Volume 104 Issue 3.]]></description>
<enclosure url="http://www.oxfordjournals.org/podcasts/jnci_104.3.summary.wav" length="7110656" type="audio/mpeg"/>
<guid>http://www.oxfordjournals.org/podcasts/jnci_104.3.summary.wav</guid>
<pubDate>THU, 26 JAN 2012 10:00:00 GMT</pubDate>
<itunes:duration>6:05</itunes:duration>
<itunes:keywords/>
</item>
<item>
<title>News Summaries for Volume 104 Issue 2</title>
<itunes:author>Oxford University Press</itunes:author>
<description><![CDATA[: Summaries of the News Stories from JNCI Volume 104 Issue 2.]]></description>
<enclosure url="http://www.oxfordjournals.org/podcasts/jnci_104.2.summary.wav" length="7110656" type="audio/mpeg"/>
<guid>http://www.oxfordjournals.org/podcasts/jnci_104.2.summary.wav</guid>
<pubDate>THU, 19 JAN 2012 10:00:00 GMT</pubDate>
<itunes:duration>7:10</itunes:duration>
<itunes:keywords/>
</item>
<item>
<title>News Summaries for Volume 104 Issue 1</title>
<itunes:author>Oxford University Press</itunes:author>
<description><![CDATA[: Summaries of the News Stories from JNCI Volume 104 Issue 1.]]></description>
<enclosure url="http://www.oxfordjournals.org/podcasts/jnci_104.1.summary.wav" length="7110656" type="audio/mpeg"/>
<guid>http://www.oxfordjournals.org/podcasts/jnci_104.1.summary.wav</guid>
<pubDate>Wed, 04 JAN 2012 10:00:00 GMT</pubDate>
<itunes:duration>8:10</itunes:duration>
<itunes:keywords/>
</item>
<item>
<title>Patient-Self Reporting Can Help Measure Clinical Outcomes</title>
<itunes:author>Oxford University Press</itunes:author>
<description><![CDATA[: Dr. Chantal Quinten discusses her involvement in a study designed to measure if patient-self reporting could compliment clinician-reported data to attain more reliable measurements of clinical outcomes.]]></description>
<enclosure url="http://www.oxfordjournals.org/podcasts/jnci_103.24.quinten.wav" length="7110656" type="audio/mpeg"/>
<guid>http://www.oxfordjournals.org/podcasts/jnci_103.24.quinten.wav</guid>
<pubDate>Wed, 04 JAN 2012 10:00:00 GMT</pubDate>
<itunes:duration>10:53</itunes:duration>
<itunes:keywords/>
</item>
<item>
<title>San Antonio Breast Cancer Symposium interview</title>
<itunes:author>Oxford University Press</itunes:author>
<description><![CDATA[: Dr. Michael Gnant of the Medical University of Vienna discusses data showing positive results on zoledronic acid and endocrine therapy for premenopausal breast cancer patients at the San Antonio Breast Cancer Symposium held Dec. 6-10.]]></description>
<enclosure url="http://www.oxfordjournals.org/podcasts/jnci_103.noissue.santo.mp3" length="7110656" type="audio/mpeg"/>
<guid>http://www.oxfordjournals.org/podcasts/jnci_103.noissue.santo.mp3</guid>
<pubDate>Thu, 15 DEC 2011 10:00:00 GMT</pubDate>
<itunes:duration>9:45</itunes:duration>
<itunes:keywords/>
</item>
<item>
<title>News Summaries for Volume 103 Issue 24</title>
<itunes:author>Oxford University Press</itunes:author>
<description><![CDATA[: Summaries of the News Stories from JNCI Volume 103 Issue 24.]]></description>
<enclosure url="http://www.oxfordjournals.org/podcasts/jnci_103.24.summary.mp3" length="7110656" type="audio/mpeg"/>
<guid>http://www.oxfordjournals.org/podcasts/jnci_103.24.summary.mp3</guid>
<pubDate>Tue, 13 DEC 2011 10:00:00 GMT</pubDate>
<itunes:duration>8:20</itunes:duration>
<itunes:keywords/>
</item>
<item>
<title>News Summaries for Volume 103 Issue 23</title>
<itunes:author>Oxford University Press</itunes:author>
<description><![CDATA[: Summaries of the News Stories from JNCI Volume 103 Issue 23.]]></description>
<enclosure url="http://www.oxfordjournals.org/podcasts/jnci_103.23.summary.mp3" length="7110656" type="audio/mpeg"/>
<guid>http://www.oxfordjournals.org/podcasts/jnci_103.23.summary.mp3</guid>
<pubDate>Mon, 28 NOV 2011 10:00:00 GMT</pubDate>
<itunes:duration>5:37</itunes:duration>
<itunes:keywords/>
</item>
<item>
<title>DNA Vaccines for Castrate-resistant prostate cancer</title>
<itunes:author>Oxford University Press</itunes:author>
<description><![CDATA[: Dr. Douglas McNeel discusses early stage studies on DNA vaccines for castrate resistant prostate cancer ahead of his presentation of the study results at the Society for Immunotherapy of Cancer annual meeting in Bethesda, held Nov. 4-6.]]></description>
<enclosure url="http://www.oxfordjournals.org/podcasts/jnci_103.noissue.mcneel.mp3" length="7110656" type="audio/mpeg"/>
<guid>http://www.oxfordjournals.org/podcasts/jnci_103.noissue.mcneel.mp3</guid>
<pubDate>Mon, 14 NOV 2011 10:00:00 GMT</pubDate>
<itunes:duration>10:24</itunes:duration>
<itunes:keywords/>
</item>
<item>
<title>Antineoplastic Agents Associated With Thyroid Dysfunction</title>
<itunes:author>Oxford University Press</itunes:author>
<description><![CDATA[: Dr. Ole-Petter Hamnvik discusses antineoplastic agents such as immunotherapies and targeted therapies that specifically target signaling pathways in cancer cells are associated with thyroid dysfunction.]]></description>
<enclosure url="http://www.oxfordjournals.org/podcasts/jnci_103.21.hamnvik.mp3" length="7110656" type="audio/mpeg"/>
<guid>http://www.oxfordjournals.org/podcasts/jnci_103.21.hamnvik.mp3</guid>
<pubDate>Tue, 18 OCT 2011 10:00:00 GMT</pubDate>
<itunes:duration>09:59</itunes:duration>
<itunes:keywords/>
</item>
<item>
<title>News Summaries for Volume 103 Issue 21</title>
<itunes:author>Oxford University Press</itunes:author>
<description><![CDATA[: Summaries of the News Stories from JNCI Volume 103 Issue 21.]]></description>
<enclosure url="http://www.oxfordjournals.org/podcasts/jnci_103.21.summary.mp3" length="7110656" type="audio/mpeg"/>
<guid>http://www.oxfordjournals.org/podcasts/jnci_103.21.summary.mp3</guid>
<pubDate>Tue, 18 OCT 2011 10:00:00 GMT</pubDate>
<itunes:duration>05:14</itunes:duration>
<itunes:keywords/>
</item>
<item>
<title>Radium 223 for bone metastases in advanced prostate cancer</title>
<itunes:author>Oxford University Press</itunes:author>
<description><![CDATA[: Dr. Chris Parker, lead investigator of the international ALSYMPCA trial of radium 223 (Alpharadin) for bone metastases in advanced prostate cancer, discusses the trial and future of this therapy following his lecture at the recent ECCO-ESMO Cancer Congress in Stockholm.]]></description>
<enclosure url="http://www.oxfordjournals.org/podcasts/jnci_103.esmo.parker.mp3" length="7110656" type="audio/mpeg"/>
<guid>http://www.oxfordjournals.org/podcasts/jnci_103.esmo.parker.mp3</guid>
<pubDate>Wed, 12 OCT 2011 10:00:00 GMT</pubDate>
<itunes:duration>06:11</itunes:duration>
<itunes:keywords/>
</item>
<item>
<title>Personalized Molecular Medicine</title>
<itunes:author>Oxford University Press</itunes:author>
<description><![CDATA[:Dr. Gordon Mills elaborates on his lecture on molecular personalized medicine at the recent ECCO-ESMO Cancer Congress in Stockholm.]]></description>
<enclosure url="http://www.oxfordjournals.org/podcasts/jnci_103.esmo.mills.mp3" length="7110656" type="audio/mpeg"/>
<guid>http://www.oxfordjournals.org/podcasts/jnci_103.esmo.mills.mp3</guid>
<pubDate>Wed, 12 OCT 2011 10:00:00 GMT</pubDate>
<itunes:duration>11:20</itunes:duration>
<itunes:keywords/>
</item>
<item>
<title>HPV Vaccine Dosage for Cervical Cancer Prevention</title>
<itunes:author>Oxford University Press</itunes:author>
<description><![CDATA[: Dr. Eduardo Franco discusses a study showing that one and two doses of HPV vaccines are just as effective as three doses for decreasing the risk of cervical cancer.]]></description>
<enclosure url="http://www.oxfordjournals.org/podcasts/jnci_103.19.franco.mp3" length="7110656" type="audio/mpeg"/>
<guid>http://www.oxfordjournals.org/podcasts/jnci_103.19.franco.mp3</guid>
<pubDate>Fri, 09 SEP 2011 10:00:00 GMT</pubDate>
<itunes:duration>09:30</itunes:duration>
<itunes:keywords/>
</item>
<item>
<title>Breast Cancer Risk Prediction Models</title>
<itunes:author>Oxford University Press</itunes:author>
<description><![CDATA[: Dr. Kathy Helzlsouer, of the Prevention and Research Center at Mercy Medical Center in Baltimore, discusses breast cancer risk prediction models based on findings from a study of a cohort of Italian women.]]></description>
<enclosure url="http://www.oxfordjournals.org/podcasts/jnci_103.12.helzlsouer.mp3" length="7110656" type="audio/mpeg"/>
<guid>http://www.oxfordjournals.org/podcasts/jnci_103.12.helzlsouer.mp3</guid>
<pubDate>Sun, 24 JUL 2011 10:00:00 GMT</pubDate>
<itunes:duration>10:00</itunes:duration>
<itunes:keywords/>
</item>
<item>
<title>Smoking Quitlines: Active vs Passive Recruitment Approaches</title>
<itunes:author>Oxford University Press</itunes:author>
<description><![CDATA[: Dr. Jennifer Vidrine, of the University of Texas MD Anderson Cancer Center, discusses active and passive recruitment methods for smoking quitlines.]]></description>
<enclosure url="http://www.oxfordjournals.org/podcasts/jnci_103.12.vidrine.mp3" length="7110656" type="audio/mpeg"/>
<guid>http://www.oxfordjournals.org/podcasts/jnci_103.12.vidrine.mp3</guid>
<pubDate>Sun, 10 JUL 2011 10:00:00 GMT</pubDate>
<itunes:duration>9:02</itunes:duration>
<itunes:keywords/>
</item>
<item>
<title>End-of-life Care Different in U.S. and Canada</title>
<itunes:author>Oxford University Press</itunes:author>
<description><![CDATA[: Dr. Joan Warren, of the National Cancer Institute, conducted a study that compared end-of-life care for lung cancer patients in Ontario and the U.S.]]></description>
<enclosure url="http://www.oxfordjournals.org/podcasts/jnci_103.11.warren.mp3" length="7110656" type="audio/mpeg"/>
<guid>http://www.oxfordjournals.org/podcasts/jnci_103.11.warren.mp3</guid>
<pubDate>Wed, 08 JUN 2011 10:00:00 GMT</pubDate>
<itunes:duration>9:30</itunes:duration>
<itunes:keywords/>
</item>
<item>
<title>Patient-Reported Family Cancer History Often Inaccurate</title>
<itunes:author>Oxford University Press</itunes:author>
<description><![CDATA[: Dr. Judy Garber, of the Dana Farber Cancer Institute in Boston, discusses how family cancer history should be integrated into personalized patient care.]]></description>
<enclosure url="http://www.oxfordjournals.org/podcasts/jnci_103.10.garber.mp3" length="7110656" type="audio/mpeg"/>
<guid>http://www.oxfordjournals.org/podcasts/jnci_103.10.garber.mp3</guid>
<pubDate>Mon, 11 MAY 2011 10:00:00 GMT</pubDate>
<itunes:duration>8:27</itunes:duration>
<itunes:keywords/>
</item>
<item>
<title>IMRT for Breast Cancer</title>
<itunes:author>Oxford University Press</itunes:author>
<description><![CDATA[Dr. Lisa Kachnic, of Boston University Medical Center, discusses how the growing usage of IMRT, or intensity-modulated radiation therapy, for breast cancer is mostly taking place in parts of the country where the procedure is reimbursed.]]></description>
<enclosure url="http://www.oxfordjournals.org/podcasts/jnci_103.10.kachnic.mp3" length="7110656" type="audio/mpeg"/>
<guid>http://www.oxfordjournals.org/podcasts/jnci_103.10.kachnic.mp3</guid>
<pubDate>Thu, 28 APR 2011 10:00:00 GMT</pubDate>
<itunes:duration>8:53</itunes:duration>
<itunes:keywords/>
</item>
<item>
<title>Annual Report to the Nation</title>
<itunes:author>Oxford University Press</itunes:author>
<description><![CDATA[Dr. Brenda Edward, one of the authors of the Annual Report to the Nation on cancer trends in the U.S., discusses this year's report, which focuses on brain tumors.  The Report showed an overall decline in cancer mortality rates.]]></description>
<enclosure url="http://www.oxfordjournals.org/podcasts/jnci_103.09.interview.mp3" length="7110656" type="audio/mpeg"/>
<guid>http://www.oxfordjournals.org/podcasts/jnci_103.09.interview.mp3</guid>
<pubDate>Thu, 31 MAR 2011 10:00:00 GMT</pubDate>
<itunes:duration>10:32</itunes:duration>
<itunes:keywords/>
</item>
<item>
<title>PSA Velocity and Prostate Cancer Screening</title>
<itunes:author>Oxford University Press</itunes:author>
<description><![CDATA[Dr. Otis Brawley discusses a study on PSA velocity showing that using PSA velocity as a prostate cancer marker would not improve patient outcomes and would lead to a large number of unnecessary biopsies]]></description>
<enclosure url="http://www.oxfordjournals.org/podcasts/jnci_103.06.interview.mp3" length="7110656" type="audio/mpeg"/>
<guid>http://www.oxfordjournals.org/podcasts/jnci_103.06.interview.mp3</guid>
<pubDate>Thu, 24 FEB 2011 10:00:00 GMT</pubDate>
<itunes:duration>10:00</itunes:duration>
<itunes:keywords/>
</item>
<item>
<title>Interview with Dr. Philip Castle</title>
<itunes:author>Oxford University Press</itunes:author>
<description><![CDATA[Dr. Interview with Dr. Philip Glass]]></description>
<enclosure url="http://www.oxfordjournals.org/podcasts/jnci_103.3.interview2.mp3" length="7110656" type="audio/mpeg"/>
<guid>http://www.oxfordjournals.org/podcasts/jnci_103.3.interview.mp3</guid>
<pubDate>Wed, 26 JAN 2011 11:00:00 GMT </pubDate>
<itunes:duration>11:55</itunes:duration>
<itunes:keywords/>
</item>
<item>
<title>Quality of Life Measures and Breast Cancer Clinical Trials</title>
<itunes:author>Oxford University Press</itunes:author>
<description><![CDATA[Dr. Patricia Ganz of UCLA discusses a review of breast cancer clinical trials that included quality of life measures as endpoints.]]></description>
<enclosure url="http://www.oxfordjournals.org/podcasts/jnci_103.3.interview.mp3" length="7110656" type="audio/mpeg"/>
<guid>http://www.oxfordjournals.org/podcasts/jnci_103.3.interview.mp3</guid>
<pubDate>Wed, 29 DEC 2010 11:00:00 GMT </pubDate>
<itunes:duration>11:55</itunes:duration>
<itunes:keywords/>
</item>
<item>
<title>Combining Genetic Risk Models to Predict Breast Cancer Risk</title>
<itunes:author>Oxford University Press</itunes:author>
<description><![CDATA[Dr. Matthew Mealiffe discusses a cohort study from the Women's Health Initiative that combines the usage of the Gail model and SNPs (single nucleotide polymorphisms) to prevent breast cancer risk.]]></description>
<enclosure url="http://www.oxfordjournals.org/podcasts/jnci_102.21.Mealiffe.mp3" length="7110656" type="audio/mpeg"/>
<guid>http://www.oxfordjournals.org/podcasts/jnci_102.21.Mealiffe.mp3</guid>
<pubDate>Thu, 09 DEC 2010 11:00:00 GMT </pubDate>
<itunes:duration>12:30</itunes:duration>
<itunes:keywords/>
</item>
<item>
<title>Estrogen Usage and Lung Cancer Incidence and Mortality</title>
<itunes:author>Oxford University Press</itunes:author>
<description><![CDATA[Dr. Rowan Chlebowski discusses an observational study from the Women's Health Initiative showing estrogen usage among post-menopausal women does not increase lung cancer incidence and mortality. ]]></description>
<enclosure url="http://www.oxfordjournals.org/podcasts/jnci_102.18.interview.mp3" length="7110656" type="audio/mpeg"/>
<guid>http://www.oxfordjournals.org/podcasts/jnci_102.18.interview.mp3</guid>
<pubDate>Thu, 28 Oct 2010 11:00 GMT</pubDate>
<itunes:duration>10:05</itunes:duration>
<itunes:keywords/>
</item>
<item>
<title>Race, Ethnicity and Breast Cancer Outcomes</title>
<itunes:author>Oxford University Press</itunes:author>
<description><![CDATA[Dr. Ian Komenaka discusses a study showing underinsured African-American women have worse breast cancer outcomes than underinsured non-Hispanic white women. ]]></description>
<enclosure url="http://www.oxfordjournals.org/podcasts/jnci_102.15.interview.mp3" length="7110656" type="audio/mpeg"/>
<guid>http://www.oxfordjournals.org/podcasts/jnci_102.15.interview.mp3</guid>
<pubDate>Wed, 28 Jul 2010 11:00 GMT</pubDate>
<itunes:duration>13:51</itunes:duration>
<itunes:keywords/>
</item>
<item>
<title>Coffee, Soft Drinks, and Colon Cancer Risk</title>
<itunes:author>Oxford University Press</itunes:author>
<description><![CDATA[Dr. Dr. Cynthia Thomson discusses a study showing little or no association between caffeinated beverages or soft drinks and risk of colon cancer.]]></description>
<enclosure url="http://www.oxfordjournals.org/podcasts/jnci_102.11.interview.mp3" length="7110656" type="audio/mpeg"/>
<guid>http://www.oxfordjournals.org/podcasts/jnci_102.11.interview.mp3</guid>
<pubDate>Fri, 18 Jun 2010 11:00 GMT</pubDate>
<itunes:duration>09:49</itunes:duration>
<itunes:keywords/>
</item>
<item>
<title>Mammography screening in young women</title>
<itunes:author>Oxford University Press</itunes:author>
<description><![CDATA[Dr. Dr. Rebecca Smith-Bindman discusses mammography in women under age 40.]]></description>
<enclosure url="http://www.oxfordjournals.org/podcasts/jnci_102.10.interview.mp3" length="7110656" type="audio/mpeg"/>
<guid>http://www.oxfordjournals.org/podcasts/jnci_102.10.interview.mp3</guid>
<pubDate>Wed, 12 May 2010 11:00 GMT</pubDate>
<itunes:duration>14:49</itunes:duration>
<itunes:keywords/>
</item>
<item>
<title>Fruits and vegetables and risk of cancer</title>
<itunes:author>Oxford University Press</itunes:author>
<description><![CDATA[Dr. Regina Ziegler discusses a large study suggesting that fruits and vegetables are associated with only a modest reduction in cancer risk.]]></description>
<enclosure url="http://www.oxfordjournals.org/podcasts/jnci_102.08.interview.mp3" length="7110656" type="audio/mpeg"/>
<guid>http://www.oxfordjournals.org/podcasts/jnci_102.08.interview.mp3</guid>
<pubDate>Mon, 19 Apr 2010 11:00 GMT</pubDate>
<itunes:duration>14:41</itunes:duration>

<itunes:keywords/>
</item>
<item>
<title>Risk of Suicide and Cardiovascular Death After Prostate Cancer Diagnosis</title>
<itunes:author>Oxford University Press</itunes:author>
<description><![CDATA[Drs. Meir Stampfer and Lorelei Mucci discuss their paper on the risks of suicide and cardiovascular death after a prostate cancer diagnosis. The article was published online in the JNCI on February 2, 2010.]]></description>
<enclosure url="http://www.oxfordjournals.org/podcasts/jnci_102.05.interview.mp3" length="13687876" type="audio/mpeg"/>
<guid>http://www.oxfordjournals.org/podcasts/jnci_102.05.interview.mp3</guid>
<pubDate>Fri, 26 Feb 2010 15:00 GMT</pubDate>
<itunes:duration>14:15</itunes:duration>
<itunes:keywords/>
</item>

<item>
<title>Summary of the February 17, 2010 issue of JNCI</title>
<itunes:author>Oxford University Press</itunes:author>
<description><![CDATA[In Issue 4 of the Journal of the National Cancer Institute, one study looked at the number of oncology and hematology drug reviews and subsequent approvals at the FDA from 2005 to 2007. Also, a study and editorial focused on symptoms and their value for early detection of ovarian cancer, while another found that three commonly used esophageal cancer cell lines in research proved to be from other cancers. In another study, researchers found that the addition of the contrast agent gadolinium during MRI for primary tumor assessment improved accuracy for detecting lymph node metastases.  And in this issue's last study, researchers found that childhood survivors of CNS cancers and leukemia have lowered educational success.]]></description>
<enclosure url="http://www.oxfordjournals.org/podcasts/jnci_102.04.mp3" length="7813460" type="audio/mpeg"/>
<guid>http://www.oxfordjournals.org/podcasts/jnci_102.04.mp3</guid>
<pubDate>Thu, 18 Feb 2010 03:00:00 GMT</pubDate>
<itunes:duration>08:08</itunes:duration>
<itunes:keywords/>
</item>
<item>
<title>Ductal Carcinoma in Situ and Its Many Unanswered Questions</title>

<itunes:author>Oxford University Press</itunes:author>
<description><![CDATA[Joann G. Elmore, M.D, MPH, professor of Medicine at the University of Washington School of Medicine, and panel chair at the National Institutes of Health state-of-the-science conference on DCIS, discusses research, treatment, and the final conference statement published in the JNCI, as well as the background paper generated for the conference and published in the JNCI in January 2010.]]></description>
<enclosure url="http://www.oxfordjournals.org/podcasts/jnci_102.03.interview.mp3" length="6740686" type="audio/mpeg"/>
<guid>http://www.oxfordjournals.org/podcasts/jnci_102.03.interview.mp3</guid>
<pubDate>Fri, 05 Feb 2010 15:00 GMT</pubDate>
<itunes:duration>13:54</itunes:duration>
<itunes:keywords/>
</item>
<item>
<title>Summary of the February 3, 2010 issue of JNCI</title>
<itunes:author>Oxford University Press</itunes:author>

<description><![CDATA[Issue 3 of the Journal of the National Cancer Institute includes a commentary and article that summarizes the latest research questions that came out of last fall's NIH state-of-the-science conference on ductal carcinoma in situ. Also in this issue, researchers found that a Chinese herbal product is associated with the risk of urinary tract cancer.  Other studies involve SNPs in C-reactive protein and cancer risk and a nationwide cohort study that investigated sexual defects in boys and testicular cancer risk. Also, a commentary looked at design issues of randomized clinical trials with biomarkers. And in the issue's last study, researchers investigated risk of colorectal, endometrial, and Lynch syndrome cancers for people with the germ-line MSH6 mutation.]]></description>
<enclosure url="http://www.oxfordjournals.org/podcasts/jnci_102.03.mp3" length="9864386" type="audio/mpeg"/>
<guid>http://www.oxfordjournals.org/podcasts/jnci_102.03.mp3</guid>
<pubDate>Mon, 01 Feb 2010 03:00:00 GMT</pubDate>
<itunes:duration>10:16</itunes:duration>
<itunes:keywords/>
</item>
<item>
<title>Summary of the January 19, 2010 issue of JNCI</title>
<itunes:author>Oxford University Press</itunes:author>
<description><![CDATA[Issue 2 of the Journal of the National Cancer Institute includes a review on cancer care and cost-effectiveness. Researchers provide a systematic overview of cost utility analysis in oncology. Also, an article and accompanying editorial look at the prevalence of right-sided tumors vs. left-sided ones after colonoscopies.  This issue also includes studies on the effects of gain-framed messages in smoking quitlines, the paracrine pathway and its role in pancreatic cancer cell invasion, and the risks of pancreatic cancer within families. And finally, in this issue's brief communication, researchers found that knockdown of transcription factor E2F1 reduces the invasive potential of melanoma cells.]]></description>
<enclosure url="http://www.oxfordjournals.org/podcasts/jnci_102.02.mp3" length="9014257" type="audio/mpeg"/>

<guid>http://www.oxfordjournals.org/podcasts/jnci_102.02.mp3</guid>
<pubDate>Tue, 19 Jan 2010 03:00:00 GMT</pubDate>
<itunes:duration>09:23</itunes:duration>
<itunes:keywords/>
</item>
<item>
<title>Treating Cancer and Protecting the Heart</title>
<itunes:author>Oxford University Press</itunes:author>
<description><![CDATA[Adriana Albini, Chief of Oncology Research of the Clinical and Research Institute MultiMedica in Milan, discusses her JNCI review article on cardio-oncology. According to the authors, cardiologists and oncologists must work together in an attempt to avoid or prevent adverse cardiovascular effects in patients from certain chemotherapies.]]></description>
<enclosure url="http://www.oxfordjournals.org/podcasts/jnci_102.01.interview.mp3" length="11901504" type="audio/mpeg"/>
<guid>http://www.oxfordjournals.org/podcasts/jnci_102.01.interview.mp3</guid>

<pubDate>Mon, 11 Jan 2010 15:16 GMT</pubDate>
<itunes:duration>12:23</itunes:duration>
<itunes:keywords/>
</item>
<item>
<title>Summary of the January 6, 2010 issue of JNCI</title>
<itunes:author>Oxford University Press</itunes:author>
<description><![CDATA[Issue 1 of the Journal of the National Cancer Institute includes a review that makes an argument for a 'cardio-oncology' field because of the risks from chemotherapy to the cardiovascular system.  Other studies include an assessment of lead time of selected ovarian cancer biomarkers, dermatologic infections in cancer patients treated with epidermal growth factor receptor inhibitor therapy, and the risk of heart disease and diabetes for patients on androgen deprivation therapy. In this issue's last study, researchers looked at DC-SCRIPT and its prognostic value in breast cancer.]]></description>
<enclosure url="http://www.oxfordjournals.org/podcasts/jnci_102.01.mp3" length="8639741" type="audio/mpeg"/>
<guid>http://www.oxfordjournals.org/podcasts/jnci_102.01.mp3</guid>
<pubDate>Thu, 07 Jan 2010 03:00:00 GMT</pubDate>

<itunes:duration>08:59</itunes:duration>
<itunes:keywords/>
</item>
<item>
<title>Summary of the December 15, 2009 issue of JNCI</title>
<itunes:author>Oxford University Press</itunes:author>
<description><![CDATA[Issue 24 of the Journal of the National Cancer Institute includes a study that found that long-term testicular cancer survivors are at high risk for Raynaud-like phenomena and neurological side effects.  The next study and accompanying editorial dealt with arsenic biomethylation and oxidative DNA damage, while another found that funeral industry workers exposed to formaldehyde face higher risk of leukemia.  One study analyzed data from the Childhood Cancer Survivor Study Report and found that late recurrence is a risk for some cancers. In the last study, researchers found evidence of a statistically significant survival benefit from adjuvant tamoxifen among patients whose estrogen receptor-positive tumors had high levels of phosphorylation of ER-alpha at serine-118. And finally, this issue's brief communication looked at trends in brain tumor incidence in 4 Scandinavian countries during a time when cell phone usage sharply increased.]]></description>
<enclosure url="http://www.oxfordjournals.org/podcasts/jnci_101.24.mp3" length="9073024" type="audio/mpeg"/>
<guid>http://www.oxfordjournals.org/podcasts/jnci_101.24.mp3.mp3</guid>
<pubDate>Tue, 15 Dec 2009 09:27:00 GMT</pubDate>
<itunes:duration>09:37</itunes:duration>

<itunes:keywords/>
</item>
<item>
<title>JNCI Interview: Lisa Schwartz and Steven Woloshin discuss the editorial "Promoting Healthy Skepticism in the News: Helping Journalists Get It Right"</title>
<itunes:author>Oxford University Press</itunes:author>
<description><![CDATA[Dartmouth's Lisa Schwartz and and Steven Woloshin speak with JNCI about their editorial that discusses the exaggerated fears and hopes that often appear in news coverage of cancer research. The editorial provides guidance for both the media and journals to help alleviate the problem.]]></description>
<enclosure url="http://www.oxfordjournals.org/podcasts/jnci_101.21.interview.mp3" length="6335816" type="audio/mpeg"/>
<guid>http://www.oxfordjournals.org/podcasts/jnci_101.23.interview.mp3</guid>
<pubDate>Mon, 7 Dec 2009 11:30:00 GMT</pubDate>
<itunes:duration>13:04</itunes:duration>
<itunes:keywords/>
</item>

<item>
<title>Summary of the December 2, 2009 issue of JNCI</title>
<itunes:author>Oxford University Press</itunes:author>
<description><![CDATA[Issue 23 of the Journal of the National Cancer Institute includes an editorial that discusses how the news media can sometimes exaggerate fears and hopes in coverage of cancer research. Also in this issue, there are studies that looked at the age-specific evaluation of HPV DNA testing vs. cytology screening and the adverse symptom reporting by patients vs. clinicians. Another study found an association between erythropoiesis-stimulating agents and venous thromboembolism.  Also in this issue, a study looked at detecting overall survival benefit derived from progression free-survival. And in this issue's brief communication, researchers looked at the effects of aspirin and folic acid on inflammation markers for colorectal adenomas.]]></description>
<enclosure url="http://www.oxfordjournals.org/podcasts/jnci_101.23.mp3" length="9245365" type="audio/mpeg"/>
<guid>http://www.oxfordjournals.org/podcasts/jnci_101.23.mp3</guid>
<pubDate>Tue, 1 Dec 2009 10:45:00 GMT</pubDate>
<itunes:duration>09:37</itunes:duration>
<itunes:keywords/>
</item>
<item>
<title>Summary of the November 17, 2009 issue of JNCI</title>

<itunes:author>Oxford University Press</itunes:author>
<description><![CDATA[Issue 22 of the Journal of the National Cancer Institute includes a study and an editorial that looked at emerging patterns in smoking and bladder cancer. Also in this issue, researchers from Italy found that people living in volcanic areas may be a greater risk for thyroid cancer.  Another study found that the small-molecule inhibitor nutlin-3 may be a viable treatment option for children with neuroblastoma with wild-type p53 activity.  One study looked at recent changes in breast cancer incidence in Spain. And in this issue's commentary, a researcher argues that a relative utility curve is a simple method to evaluate risk prediction in a medical decision-making framework.]]></description>
<enclosure url="http://www.oxfordjournals.org/podcasts/jnci_101.22.mp3" length="7429750" type="audio/mpeg"/>
<guid>http://www.oxfordjournals.org/podcasts/jnci_101.22.mp3</guid>
<pubDate>Mon, 23 Nov 2009 10:45:00 GMT</pubDate>
<itunes:duration>07:44</itunes:duration>
<itunes:keywords/>
</item>
<item>
<title>JNCI Interview: Dr. Gadi Rennert discusses cancer risks for Jewish survivors of the Holocaust</title>
<itunes:author>Oxford University Press</itunes:author>

<description><![CDATA[Dr. Rennert of the National Center of Cancer Control in Haifa, Israel, discusses the JNCI article that found that Jewish survivors of World War II who were potentially exposed to the Holocaust are at a higher risk for cancer occurrence]]></description>
<enclosure url="http://www.oxfordjournals.org/podcasts/jnci_101.21.interview.mp3" length="6180864" type="audio/mpeg"/>
<guid>http://www.oxfordjournals.org/podcasts/jnci_101.21.interview.mp3</guid>
<pubDate>Wed, 18 Nov 2009 15:30:00 GMT</pubDate>
<itunes:duration>12:44</itunes:duration>
<itunes:keywords/>
</item>
<item>
<title>Summary of the November 3, 2009 issue of JNCI</title>
<itunes:author>Oxford University Press</itunes:author>
<description><![CDATA[Issue 21 of the Journal of the National Cancer Institute features a study and editorial on Jewish survivors of World War II who were potentially exposed to the Holocaust and their risk for cancer occurrence. In this issue's first commentary, researchers propose a more efficient system using archived specimens for the evaluation of prognostic and predictive biomarkers. The second commentary summarizes a set of critical decision points in cancer biomarker and drug development.  This issue also includes a study that found that women with increased levels of M&#252;llerian inhibiting substance may be at a greater risk for breast cancer. In this issue's last study, researchers found that Merkel cell polyomavirus is the only human polyomavirus known to be associated with a rare skin cancer.]]></description>
<enclosure url="http://www.oxfordjournals.org/podcasts/jnci_101.21.mp3" length="7467008" type="audio/mpeg"/>

<guid>http://www.oxfordjournals.org/podcasts/jnci_101.21.mp3</guid>
<pubDate>Wed, 18 Nov 2009 15:30:00 GMT</pubDate>
<itunes:duration>07:46</itunes:duration>
<itunes:keywords/>
</item>
<item>
<title> "Personalized Telephone Counseling For Teen Smokers" - Editorialist Dr. Scott Leischow discusses two linked studies on teen smoking cessation.</title>
<itunes:author>Oxford University Press</itunes:author>
<description><![CDATA[Personalized, proactive telephone counseling centered on motivational interviewing and cognitive behavioral skills training has been found to favorably impact quit rates among teen smokers. Dr. Leischow shares his thoughts on the design, results and importance of studies.]]></description>
<enclosure url="http://www.oxfordjournals.org/podcasts/jnci_101.20.interview.mp3" length="12814255" type="audio/mpeg"/>
<guid>http://www.oxfordjournals.org/podcasts/jnci_101.20.interview.mp3</guid>

<pubDate>Mon, 09 Nov 2009 15:30:00 GMT</pubDate>
<itunes:duration>13:20</itunes:duration>
<itunes:keywords/>
</item>
<item>
<title>Summary of the October 20, 2009 issue of JNCI</title>
<itunes:author>Oxford University Press</itunes:author>
<description><![CDATA[Issue 20 of the Journal of the National Cancer Institute includes two studies that found that proactive, personalized phone counseling could help teen smokers quit. Another study confirmed previous findings on the STD Trichomonas vaginalis and its association with prostate cancer. In another study, researchers found that investing in screening programs now could cut future, more expensive chemotherapy treatment costs in half. And finally, in this issue's brief communication: new research suggests that moles are polyclonal with respect to BRAF gene mutations, and that BRAF is mutated after the development of the mole.]]></description>
<enclosure url="http://www.oxfordjournals.org/podcasts/jnci_101.20.mp3" length="6673102" type="audio/mpeg"/>
<guid>http://www.oxfordjournals.org/podcasts/jnci_101.20.mp3</guid>
<pubDate>Mon, 09 Nov 2009 15:30:00 GMT</pubDate>

<itunes:duration>06:57</itunes:duration>
<itunes:keywords/>
</item>
<item>
<title>Summary of the October 6, 2009 issue of JNCI</title>
<itunes:author>Oxford University Press</itunes:author>
<description><![CDATA[Issue 19 of the Journal of the National Cancer Institute includes a study on liver cancer reduction from HBV vaccinations and a study and accompanying editorial on prostate cancer overdiagnosis. This issue also includes a study on SNPs linked with prostate cancer in Japanese men; a study on surgeon training on the breast cancer sentinel node; a study looking at mastectomy decisions among breast cancer patients; and finally a review of the literature on biomarkers for outcome of EGFR-targeted therapy for metastatic colorectal cancer.]]></description>
<enclosure url="http://www.oxfordjournals.org/podcasts/jnci_101.19.mp3" length="10805248" type="audio/mpeg"/>
<guid>http://www.oxfordjournals.org/podcasts/jnci_101.19.mp3</guid>
<pubDate>Mon, 05 Oct 2009 10:30:00 GMT</pubDate>
<itunes:duration>11:14</itunes:duration>

<itunes:keywords/>
</item>
<item>
<title>Summary of the September 15, 2009 issue of JNCI</title>
<itunes:author>Oxford University Press</itunes:author>
<description><![CDATA[Issue 18 of the JNCI includes a study and an editorial on the contribution of clinical breast examination to breast cancer screening and a study and an editorial on using fecal DNA methylation to detect gastric and colorectal cancers. This issue also includes studies on melanosomes and sensitivity of melanoma cells to chemotherapy; the risk of prostate cancer from high serum insulin levels; and a brief communication that profiles prostate cancer diagnosis and racial disparities in the U.S.]]></description>
<enclosure url="http://www.oxfordjournals.org/podcasts/jnci_101.18.mp3" length="14340096" type="audio/mpeg"/>
<guid>http://www.oxfordjournals.org/podcasts/jnci_101.18.mp3</guid>
<pubDate>Tue, 22 Sep 2009 12:00:00 GMT</pubDate>
<itunes:duration>09:57</itunes:duration>
<itunes:keywords/>
</item>

<item>
<title>Combination vs. sequential single-agent-Dr. Eric Winer discusses both chemotherapy options for women with metastatic breast cancer.</title>
<itunes:author>Oxford University Press</itunes:author>
<description><![CDATA[Combination vs. sequential single-agent chemotherapy: Co-author of recent commentary, Dr. Eric Winer, discusses both options for women with metastatic breast cancer.]]></description>
<enclosure url="http://www.oxfordjournals.org/podcasts/jnci_101.17.interview.mp3" length="18145280" type="audio/mpeg"/>
<guid>http://www.oxfordjournals.org/podcasts/jnci_101.17.interview.mp3</guid>
<pubDate>Tue, 22 Sep 2009 12:00:00 GMT</pubDate>
<itunes:duration>12:35</itunes:duration>
<itunes:keywords/>
</item>
<item>
<title>Summary of the September 1, 2009 issue of JNCI</title>

<itunes:author>Oxford University Press</itunes:author>
<description><![CDATA[Issue 17 of the JNCI includes a commentary on the use of combination versus sequential chemotherapy in metastatic breast cancer and a study and editorial on the cost-effectiveness of cetuximab in metastatic colorectal cancer. This issue also includes research on an antibody that showed anticancer activity in ovarian cancer cell lines and a study and accompanying editorial on the overestimation of the benefits of cancer screening. In the last study, researchers evaluated whether non-skin cancer was independently associated with vulnerability and frailty in older people.]]></description>
<enclosure url="http://www.oxfordjournals.org/podcasts/jnci_101.17.mp3" length="9122905" type="audio/mpeg"/>
<guid>http://www.oxfordjournals.org/podcasts/jnci_101.17.mp3</guid>
<pubDate>Tue, 01 Sep 2009 15:00:00 GMT</pubDate>
<itunes:duration>09:30</itunes:duration>
<itunes:keywords/>
</item>
<item>
<title>Summary of the August 18, 2009 issue of JNCI</title>
<itunes:author>Oxford University Press</itunes:author>

<description><![CDATA[Issue 16 of the JNCI includes studies and accompanying editorials on the risk of HPV-related cancers for AIDS patients and the long-term health and social outcomes for neuroblastoma survivors.  This issue also includes a commentary on improving the biomarker pipeline to evaluate and develop cancer screening tests and a study on MEK4 function and genistein treamtment in prostate cancer cells.]]></description>
<enclosure url="http://www.oxfordjournals.org/podcasts/jnci_101.16.mp3" length="7237425" type="audio/mpeg"/>
<guid>http://www.oxfordjournals.org/podcasts/jnci_101.16.mp3</guid>
<pubDate>Thu, 27 Aug 2009 13:00:00 GMT</pubDate>
<itunes:duration>07:32</itunes:duration>
<itunes:keywords/>
</item>
<item>
<title>How Much is Life Worth? Dr. Peter Bach discusses the use of expensive cancer drugs</title>
<itunes:author>Oxford University Press</itunes:author>
<description><![CDATA[Dr. Bach of Memorial Sloan-Kettering discusses the JNCI commentary on the use of expensive cancer drugs that only produce marginal benefits]]></description>
<enclosure url="http://www.oxfordjournals.org/podcasts/jnci_101.15.interview.mp3" length="14315520" type="audio/mpeg"/>

<guid>http://www.oxfordjournals.org/podcasts/jnci_101.15.interview.mp3</guid>
<pubDate>Thu, 20 Aug 2009 14:00:00 GMT</pubDate>
<itunes:duration>13:03</itunes:duration>
<itunes:keywords/>
</item>
<item>
<title>Summary of the July 28, 2009 issue of JNCI</title>
<itunes:author>Oxford University Press</itunes:author>
<description><![CDATA[The July 28 online issue of the Journal of the National Cancer Institute includes a commentary on the cost cancer therapies versus their extension of survival; a study that looks at the associations between hepatitis B and liver cancer; and a study on thalidomide's use against small cell lung cancer, with an accompanying editorial. Also in this issue, one study looked at second primary breast cancer occurrence according to hormone receptor status; the last study analyzed the cost-effectiveness of HPV vaccinations in the Netherlands.]]></description>
<enclosure url="http://www.oxfordjournals.org/podcasts/jnci_101.15.mp3" length="11075584" type="audio/mpeg"/>
<guid>http://www.oxfordjournals.org/podcasts/jnci_101.15.mp3</guid>

<pubDate>Mon, 20 Jul 2009 13:00:00 GMT</pubDate>
<itunes:duration>07:16</itunes:duration>
<itunes:keywords/>
</item>
<item>
<title>Summary of the July 7, 2009 issue of JNCI</title>
<itunes:author>Oxford University Press</itunes:author>
<description><![CDATA[The July 7 online issue of the Journal of the National Cancer Institute includes two studies that shed light on racial disparities in cancer survival, with an accompanying editorial; a study linking dietary fats to pancreatic cancer; a study on the risk of liver cancer in women with hepatitis B virus; and a study on the risk of breast cancer and a single-nucleotide polymorphism.]]></description>
<enclosure url="http://www.oxfordjournals.org/podcasts/jnci_101.14.mp3" length="11075584" type="audio/mpeg"/>
<guid>http://www.oxfordjournals.org/podcasts/jnci_101.14.mp3</guid>
<pubDate>Tue, 14 Jul 2009 14:00:00 GMT</pubDate>

<itunes:duration>07:41</itunes:duration>
<itunes:keywords/>
</item>
<item>
<title>Dr. Lucille Dorresteijn and Dr. Dan Longo discuss the risk of stroke for Hodgkin lymphoma patients</title>
<itunes:author>Oxford University Press</itunes:author>
<description><![CDATA[Interview with Dr. Lucille D. A. Dorresteijn and editorialist Dr. Dan Longo about risk of stroke and transient ischemic attack for patients treated for Hodgkin lymphoma with radiation therapy]]></description>
<enclosure url="http://www.oxfordjournals.org/podcasts/jnci_101.13.interview.mp3" length="12537856" type="audio/mpeg"/>
<guid>http://www.oxfordjournals.org/podcasts/jnci_101.13.interview.mp3</guid>
<pubDate>Fri, 10 Jul 2009 17:00:00 GMT</pubDate>
<itunes:duration>13:03</itunes:duration>

<itunes:keywords/>
</item>
<item>
<title>Summary of the June 23, 2009 issue of JNCI</title>
<itunes:author>Oxford University Press</itunes:author>
<description><![CDATA[The June 23 issue of the JNCI includes a study on a new candidate tumor suppressor gene and biomarker in colorectal cancer and another that looked at Hodgkin lymphoma survivors and their risk of stroke. This issue also features a study on the subsequent medical risks associated with survivors of childhood central nervous system cancer; a study that added seven single-nucleotide polymorphisms to the Breast Cancer Risk Assessment Tool to improve its accuracy; and finally, a study that looked at a polyomavirus's association with Merkel cell carcinoma.]]></description>
<enclosure url="http://www.oxfordjournals.org/podcasts/jnci_101.13.mp3" length="8306688" type="audio/mpeg"/>
<guid>http://www.oxfordjournals.org/podcasts/jnci_101.13.mp3</guid>
<pubDate>Wed, 01 Jul 2009 11:00:00 GMT</pubDate>
<itunes:duration>08:38</itunes:duration>
<itunes:keywords/>
</item>

<item>
<title>Summary of the June 9, 2009 issue of JNCI</title>
<itunes:author>Oxford University Press</itunes:author>
<description><![CDATA[The June 9 online issue of the JNCI includes a study that found variability in pancreatic cancer care with newly developed quality indicators; a study focusing on autoimmune antibodies and improved outcome in melanoma patients; and a study looking at risk assessment for prostate cancer metastasis and mortality. In addition, two studies and an editorial discuss health-related quality of life after cancer diagnosis.]]></description>
<enclosure url="http://www.oxfordjournals.org/podcasts/jnci_101.12.mp3" length="8220672" type="audio/mpeg"/>
<guid>http://www.oxfordjournals.org/podcasts/jnci_101.12.mp3</guid>
<pubDate>Tue, 16 Jun 2009 10:00:00 GMT</pubDate>
<itunes:duration>08:33</itunes:duration>
<itunes:keywords/>
</item>
<item>
<title>Interview with Dr. John Schiller about a possible new HPV vaccine.</title>

<itunes:author>Oxford University Press</itunes:author>
<description><![CDATA[Dr. Schiller talks about research on a candidate, broad-spectrum HPV vaccine that has the potential to prevent more cervical cancers and be less expensive than current vaccines.]]></description>
<enclosure url="http://www.oxfordjournals.org/podcasts/jnci_101.11.interview.mp3" length="11071488" type="audio/mpeg"/>
<guid>http://www.oxfordjournals.org/podcasts/jnci_101.11.interview.mp3</guid>
<pubDate>Tue, 02 Jun 2009 17:00:00 GMT</pubDate>
<itunes:duration>11:31</itunes:duration>
<itunes:keywords/>
</item>
<item>
<title>Summary of the June 2, 2009 issue of JNCI</title>
<itunes:author>Oxford University Press</itunes:author>

<description><![CDATA[The June 2 issue of JNCI highlights a study and editorial on a new broad-spectrum vaccine for cervical cancer. It also includes a study on the protein known as phosphatase 2A or CIP2A in gastric cancer; the lifelong cancer incidence in patients treated for childhood cancer; the variability in how accurately different facilities interpret diagnostic mammograms; and the peptide RasGAP's effect on colon cancer in mice.]]></description>
<enclosure url="http://www.oxfordjournals.org/podcasts/jnci_101.11.mp3" length="11157504" type="audio/mpeg"/>
<guid>http://www.oxfordjournals.org/podcasts/jnci_101.11.mp3</guid>
<pubDate>Tue, 02 Jun 2009 17:00:00 GMT</pubDate>
<itunes:duration>07:44</itunes:duration>
<itunes:keywords/>
</item>
<item>
<title>Summary of the May 19 issue of JNCI</title>
<itunes:author>Oxford University Press</itunes:author>
<description><![CDATA[The May 19 online issue of the JNCI includes a study on the long-term risks of invasive cancer and recurrence of severe cervical intraepithelial neoplasia (CIN); a review of traditional and updated phase I trial designs; and a population-based study and editorial examining the association between lymphovascular invasion and high risk breast cancer. This issue also highlights data showing how four immunohistochemistry tests can distinguish between luminal A and B breast cancer subtypes; an extended follow-up examining occupational formaldehyde exposure and cancer risk; and a mouse study demonstrating that peroxisome proliferator-activated receptor-delta is involved in colon cancer formation. ]]></description>
<enclosure url="http://www.oxfordjournals.org/podcasts/jnci_101.10.mp3" length="8720384" type="audio/mpeg"/>

<guid>http://www.oxfordjournals.org/podcasts/jnci_101.10.mp3</guid>
<pubDate>Tue, 19 May 2009 15:00:00 GMT</pubDate>
<itunes:duration>09:04</itunes:duration>
<itunes:keywords/>
</item>
<item>
<title> Interview with Dr. Hans-Olov Adami about dietary acrylamide and the risk of cancer.</title>
<itunes:author>Oxford University Press</itunes:author>
<description><![CDATA[Dr. Adami talks about a new study showing how acrylamide, which is formed in some starchy foods, such as potato chips and French fries, during high-temperature cooking, was not associated with an increased risk of lung cancer in mean.  Investigators found no statistically significant difference in lung cancer incidence in men who consumed the highest and lowest amounts of acrylamide-containing foods. By contrast, the researchers found that women who ate the most acrylamide-containing foods had a statistically significant lower incidence of lung cancer compared with those in the group who consumed the least acrylamide-containing foods.]]></description>
<enclosure url="http://www.oxfordjournals.org/podcasts/jnci_101.09.interview.mp3" length="18575952" type="audio/mpeg"/>
<guid>http://www.oxfordjournals.org/podcasts/jnci_101.09.interview.mp3</guid>

<pubDate>Fri, 08 May 2009 10:00:00 GMT</pubDate>
<itunes:duration>12:53</itunes:duration>
<itunes:keywords/>
</item>
<item>
<title>Summary of the May 5 issue of JNCI</title>
<itunes:author>Oxford University Press</itunes:author>
<description><![CDATA[The May 5 issue of JNCI includes a report about dietary acrylamide and its association with lung cancer risk and a study on gene alterations in response to anthracycline-based therapy. The issue also includes a commentary describing the design of clinical trials to test the impact of physical activity and weight control on breast cancer risk and a study showing that the clusterin gene acts as a tumor suppressor in mouse models of neuroblastoma. Last, there is a report showing that Danish women who are survivors of pediatric cancer are no more likely to terminate a pregnancy than their sisters or women in the general population.]]></description>
<enclosure url="http://www.oxfordjournals.org/podcasts/jnci_101.09.mp3" length="12538896" type="audio/mpeg"/>
<guid>http://www.oxfordjournals.org/podcasts/jnci_101.09.mp3</guid>
<pubDate>Wed, 08 Apr 2009 10:00:00 GMT</pubDate>

<itunes:duration>08:42</itunes:duration>
<itunes:keywords/>
</item>
<item>
<title>Summary of the April 7 online issue of JNCI </title>
<itunes:author>Oxford University Press</itunes:author>
<description><![CDATA[The April 7 online issue of the Journal of the National Cancer Institute has reports on the origin of multifocal lung cancers and on the relationship between intensive treatment and survival in bladder cancer. Also in this issue are studies on subsequent cancers in long-term survivors of retinoblastoma; the role of cytokine signaling in mouse models of gastric cancer; and the lack of association between two perfluorinated chemicals and common cancers. Last, there is a report from a workshop at the National Institutes of Health on the interrelatedness of chronic obstructive pulmonary disease and lung cancer.]]></description>
<enclosure url="http://www.oxfordjournals.org/podcasts/jnci_101.08.mp3" length="13387920" type="audio/mpeg"/>
<guid>http://www.oxfordjournals.org/podcasts/jnci_101.08.mp3</guid>
<pubDate>Tue, 14 Apr 2009 16:57:00 GMT</pubDate>
<itunes:duration>09:17</itunes:duration>

<itunes:keywords/>
</item>
<item>
<title>Distribution of Human Papillomavirus Types</title>
<itunes:author>Oxford University Press</itunes:author>
<description><![CDATA[Dr. Cosette Wheeler talks about a study of HPV types and issues related to screening and vaccination for HPV.]]></description>
<enclosure url="http://www.oxfordjournals.org/podcasts/jnci_101.07.interview.mp3" length="22930512" type="audio/mpeg"/>
<guid>http://www.oxfordjournals.org/podcasts/jnci_101.07.interview.mp3</guid>
<pubDate>Wed, 01 Apr 2009 16:00:00 GMT</pubDate>
<itunes:duration>15:55</itunes:duration>
<itunes:keywords/>
</item>

<item>
<title>Summary of the April 1 issue of JNCI</title>
<itunes:author>Oxford University Press</itunes:author>
<description><![CDATA[Dr. Cosette Wheeler talks about a study of HPV types and issues related to screening and vaccination for HPV.]]></description>
<enclosure url="http://www.oxfordjournals.org/podcasts/jnci_101.07.mp3" length="13504272" type="audio/mpeg"/>
<guid>http://www.oxfordjournals.org/podcasts/jnci_101.07.mp3</guid>
<pubDate>Wed, 01 Apr 2009 16:00:00 GMT</pubDate>
<itunes:duration>09:22</itunes:duration>
<itunes:keywords/>
</item>
<item>
<title>Summary of the March 18 issue of JNCI</title>

<itunes:author>Oxford University Press</itunes:author>
<description><![CDATA[The March 18 issue of JNCI includes one study on estimating the risk of breast cancer and another on overdiagnosis and lead times in PSA screening for prostate cancer. Also in this issue is a study suggesting that folic acid supplements increase the risk of prostate cancer; a study showing how herpesvirus may interfere with cell death; mechanistic data linking human papillomavirus to head and neck cancer; and a study suggesting that some blood types are associated with an elevated risk of pancreatic cancer.]]></description>
<enclosure url="http://www.oxfordjournals.org/podcasts/jnci_101.06.mp3" length="13594576" type="audio/mpeg"/>
<guid>http://www.oxfordjournals.org/podcasts/jnci_101.06.mp3</guid>
<pubDate>Wed, 18 Mar 2009 11:00:00 GMT</pubDate>
<itunes:duration>09:26</itunes:duration>
<itunes:keywords/>
</item>
<item>
<title>Interview with Dr. Michael Lauer about moderate alcohol consumption and the risk of cancer</title>
<itunes:author>Oxford University Press</itunes:author>

<description><![CDATA[Dr. Lauer talks about a new study showing that even moderate amounts alcohol increase a woman's risk of cancer. The analysis of data from the U.K.'s Million Women Study showed that moderate alcohol consumption among women is associated with a statistically significant increase in cancer risk and may account for nearly 13 percent of the cancers of the breast, liver, rectum, and upper aero-digestive tract combined.]]></description>
<enclosure url="http://www.oxfordjournals.org/podcasts/jnci_101.05.interview.mp3" length="18251664" type="audio/mpeg"/>
<guid>http://www.oxfordjournals.org/podcasts/jnci_101.05.interview.mp3</guid>
<pubDate>Wed, 04 Mar 2009 14:00:00 GMT</pubDate>
<itunes:duration>12:40</itunes:duration>
<itunes:keywords/>
</item>
<item>
<title>Summary of the March 4 issue of JNCI</title>
<itunes:author>Oxford University Press</itunes:author>
<description><![CDATA[The March 4 issue of JNCI includes a study showing that even moderate alcohol consumption in women increases the risk of cancer; an analysis of the relationship between smoking, lung cancer risk, and socioeconomic status in Europeans; and a study showing that the drug Goserelin improves long-term survival in premenopausal women with early breast cancer. Also in this issue are clinical trial results showing that gene expression patterns change in prostate tumors after just a few weeks of vitamin E and selenium use; a study showing that a model called 'MMRpredict' is best able to identify colorectal cancer patients who should undergo genetic testing; and an animal study demonstrating that a fluorescent fusion protein can be used to track cancer stem cells.]]></description>
<enclosure url="http://www.oxfordjournals.org/podcasts/jnci_101.05.mp3" length="13614864" type="audio/mpeg"/>

<guid>http://www.oxfordjournals.org/podcasts/jnci_101.05.mp3</guid>
<pubDate>Wed, 04 Mar 2009 14:00:00 GMT</pubDate>
<itunes:duration>09:27</itunes:duration>
<itunes:keywords/>
</item>
<item>
<title>Summary of the February 18 issue of JNCI</title>
<itunes:author>Oxford University Press</itunes:author>
<description><![CDATA[The February 18 issue of JNCI features articles on two different treatments for advanced cancer of the larynx or hypotharynx; optimal strategies for cervical cancer screening; and a gene mutation that may be associated with both goiter and thyroid. Also in the Journal are articles on the radiation risks of mammography in women with BRCA mutations; human papillomavirus type 18 in precancerous lesions of the cervix; the role of the protein, STAT-3, in the anti-tumor effects of a compound found in cruciferous vegetables; and a gene mutation associated with resistence to the drug imatinib.]]></description>
<enclosure url="http://www.oxfordjournals.org/podcasts/jnci_101.04.mp3" length="12814244" type="audio/mpeg"/>
<guid>http://www.oxfordjournals.org/podcasts/jnci_101.04.mp3</guid>

<pubDate>Tue, 17 Feb 2009 17:00:00 GMT</pubDate>
<itunes:duration>08:53</itunes:duration>
<itunes:keywords/>
</item>
<item>
<title>Treating Cancer of the Larynx</title>
<itunes:author>Oxford University Press</itunes:author>
<description><![CDATA[Dr. Arlene Forastiere talks about a trial that compared two treatments for throat cancer.]]></description>
<enclosure url="http://www.oxfordjournals.org/podcasts/jnci_101.03.interview.mp3" length="16734481" type="audio/mpeg"/>
<guid>http://www.oxfordjournals.org/podcasts/jnci_101.03.interview.mp3</guid>
<pubDate>Tue, 03 Feb 2009 17:00:00 GMT</pubDate>

<itunes:duration>13:39</itunes:duration>
<itunes:keywords/>
</item>
<item>
<title>Summary of the February 4 issue of JNCI</title>
<itunes:author>Oxford University Press</itunes:author>
<description><![CDATA[The February 4th issue of JNCI features articles on two different treatments for advanced cancer of the larynx or hypotharynx; optimal strategies for cervical cancer screening; and a gene mutation that may be associated with both goiter and thyroid. Also in the Journal are articles on the radiation risks of mammography in women with BRCA mutations; human papillomavirus type 18 in precancerous lesions of the cervix; the role of the protein, STAT-3, in the anti-tumor effects of a compound found in cruciferous vegetables; and a gene mutation associated with resistence to the drug imatinib.]]></description>
<enclosure url="http://www.oxfordjournals.org/podcasts/jnci_101.03.mp3" length="12115968" type="audio/mpeg"/>
<guid>http://www.oxfordjournals.org/podcasts/jnci_101.03.mp3</guid>
<pubDate>Tue, 03 Feb 2009 17:00:00 GMT</pubDate>
<itunes:duration>08:55</itunes:duration>

<itunes:keywords/>
</item>
<item>
<title>Summary of the January 21 issue of JNCI</title>
<itunes:author>Oxford University Press</itunes:author>
<description><![CDATA[The January 21 issue of JNCI includes studies on removing the ovaries and fallopian tubes to reduce cancer risk in women with mutations in BRCA-1 or BRCA-2 genes; various screening strategies for cervical cancer; the effect of the drug lapatinib on breast cancer cells that are estrogen receptor negative; a molecular marker for predicting outcome in bladder cancer; the lack of association between mobile phones and uveal melanoma; and single vs tandem stem cell transplants in multiple myeloma.]]></description>
<enclosure url="http://www.oxfordjournals.org/podcasts/jnci_101.02.mp3" length="13139968" type="audio/mpeg"/>
<guid>http://www.oxfordjournals.org/podcasts/jnci_101.02.mp3</guid>
<pubDate>Tue, 20 Jan 2009 10:00:00 GMT</pubDate>
<itunes:duration>09:07</itunes:duration>
<itunes:keywords/>
</item>

<item>
<title>Summary of January 7 issue of JNCI</title>
<itunes:author>Oxford University Press</itunes:author>
<description><![CDATA[The January 7 issue of JNCI features articles on antioxidants for cancer prevention; ways to assess the credibility of data showing an association between gene variants and cancer; and the biological mechanisms underlying hearing loss after treatment with the chemotherapy drug, cisplatin; the association between insulin and insulin-like growth factor and breast cancer, and the detection of different types of breast cancer cells in peripheral blood.]]></description>
<enclosure url="http://www.oxfordjournals.org/podcasts/jnci_101.01.mp3" length="8475652" type="audio/mpeg"/>
<guid>http://www.oxfordjournals.org/podcasts/jnci_101.01.mp3</guid>
<pubDate>Tue, 06 Jan 2009 10:00:00 GMT</pubDate>
<itunes:duration>05:53</itunes:duration>
<itunes:keywords/>
</item>
<item>
<title>Summary of the December 17 Issue of JNCI</title>

<itunes:author>Oxford University Press</itunes:author>
<description><![CDATA[The December 17 issue of JNCI features articles on the value of life lost from the cancer deaths, chemotherapy and targeted therapies for advanced breast cancer, glucocorticoid resistance in acute lymphoblastic leukemia, breast cancer incidence rates among black and white women, genomic instability induced by DNA structure, fecal occult blood test screening for colorectal cancer, and the risk of second cancers in survivors of retinoblastoma.]]></description>
<enclosure url="http://www.oxfordjournals.org/podcasts/jnci_100.24.mp3" length="13624082" type="audio/mpeg"/>
<guid>http://www.oxfordjournals.org/podcasts/jnci_100.24.mp3</guid>
<pubDate>Tue, 16 Dec 2008 17:00:00 GMT</pubDate>
<itunes:duration>09:27</itunes:duration>
<itunes:keywords/>
</item>
<item>
<title>Annual Report to the Nation on the Status of Cancer</title>
<itunes:author>Oxford University Press</itunes:author>

<description><![CDATA[Dr. Ahmedin Jemal discusses the most recent statistics on cancer incidence and mortality in the U.S.]]></description>
<enclosure url="http://www.oxfordjournals.org/podcasts/jnci_100.23.interview.mp3" length="16734481" type="audio/mpeg"/>
<guid>http://www.oxfordjournals.org/podcasts/jnci_100.23.interview.mp3</guid>
<pubDate>Thu, 04 Dec 2008 17:00:00 GMT</pubDate>
<itunes:duration>11:37</itunes:duration>
<itunes:keywords/>
</item>
<item>
<title>Summary of the December 3 Issue of JNCI</title>
<itunes:author>Oxford University Press</itunes:author>
<description><![CDATA[The December 3 issue of JNCI features the annual report to the nation on the status of cancer, as well as articles on diet and renal cell cancer risk, lymphadenectomy in early-stage endometrial cancer, body weight and breast cancer risk, the association between LINE-1 hypomethylation and shorter colon cancer    survival, and a tracking registry to reduce racial disparities in breast cancer care.]]></description>
<enclosure url="http://www.oxfordjournals.org/podcasts/jnci_100.23.mp3" length="12115968" type="audio/mpeg"/>

<guid>http://www.oxfordjournals.org/podcasts/jnci_100.23.mp3</guid>
<pubDate>Thu, 04 Dec 2008 17:00:00 GMT</pubDate>
<itunes:duration>08:24</itunes:duration>
<itunes:keywords/>
</item>
<item>
<title>Summary of the November 19 Issue of JNCI</title>
<itunes:author>Oxford University Press</itunes:author>
<description><![CDATA[The November 19 issue of JNCI features articles on the effect of calcium and vitamin D supplements on breast cancer risk, cigarette smoke and expression of potential lung cancer oncogene, isolated breast cancer cells in sentinel lymph nodes, seven-in-absentia homolog 2 and lung cancer, lysophosphatidic acid signaling in ovarian cancer, breast cancer trends among younger women, and squamous cell carcinomas in Fanconi anemia patients.]]></description>
<enclosure url="http://www.oxfordjournals.org/podcasts/jnci_100.22.mp3" length="13740996" type="audio/mpeg"/>
<guid>http://www.oxfordjournals.org/podcasts/jnci_100.22.mp3</guid>

<pubDate>Tue, 18 Nov 2008 10:00:00 GMT</pubDate>
<itunes:duration>09:32</itunes:duration>
<itunes:keywords/>
</item>
<item>
<title>Improving Rodent Models for Preclinical Research</title>
<itunes:author>Oxford University Press</itunes:author>
<description><![CDATA[Dr. Melinda Hollingshead discusses how to improve preclinical trial designs and speed up cancer drug development.]]></description>
<enclosure url="http://www.oxfordjournals.org/podcasts/jnci_100.21.interview.mp3" length="18898944" type="audio/mpeg"/>
<guid>http://www.oxfordjournals.org/podcasts/jnci_100.21.interview.mp3</guid>
<pubDate>Tue, 04 Nov 2008 10:00:00 GMT</pubDate>

<itunes:duration>13:07</itunes:duration>
<itunes:keywords/>
</item>
<item>
<title>Summary of the November 5 Issue of JNCI</title>
<itunes:author>Oxford University Press</itunes:author>
<description><![CDATA[The November 5 issue of JNCI features articles on new guidelines for testing cancer drugs in mice, the association between statin use and PSA level, X chromosome inactivation in breast and ovarian cancer, an evaluation of the Impact of Cancer Scale, characteristics and treatment patterns of patients with myelodysplastic syndromes, and the association of a genetic region with an increased risk of lung cancer.]]></description>
<enclosure url="http://www.oxfordjournals.org/podcasts/jnci_100.21.mp3" length="12054528" type="audio/mpeg"/>
<guid>http://www.oxfordjournals.org/podcasts/jnci_100.21.mp3</guid>
<pubDate>Tue, 04 Nov 2008 10:00:00 GMT</pubDate>
<itunes:duration>08:48</itunes:duration>

<itunes:keywords/>
</item>
<item>
<title>Summary of the October 15 Issue of JNCI</title>
<itunes:author>Oxford University Press</itunes:author>
<description><![CDATA[The October 15 issue of JNCI features articles on a new study design for evaluating biomarkers, the association between NSAID use and breast cancer risk, tamoxifen treatment and the detection of estrogen receptor-negative breast cancer, sorafinib to treat older patients with renal cell carcinoma, a mediator of malignant pleural effusion, and risk factors for male breast cancer.]]></description>
<enclosure url="http://www.oxfordjournals.org/podcasts/jnci_100.20.mp3" length="21155840" type="audio/mpeg"/>
<guid>http://www.oxfordjournals.org/podcasts/jnci_100.20.mp3</guid>
<pubDate>Tue, 14 Oct 2008 10:00:00 GMT</pubDate>
<itunes:duration>14:41</itunes:duration>
<itunes:keywords/>
</item>

<item>
<title>Childhood Cancer Survivors</title>
<itunes:author>Oxford University Press</itunes:author>
<description><![CDATA[Dr. Anna Meadows discusses improvements in treatments and survival rates for childhood cancer survivors.]]></description>
<enclosure url="http://www.oxfordjournals.org/podcasts/jnci_100.19.interview.mp3" length="18504516" type="audio/mpeg"/>
<guid>http://www.oxfordjournals.org/podcasts/jnci_100.19.interview.mp3</guid>
<pubDate>Tue, 30 Sep 2008 10:00:00 GMT</pubDate>
<itunes:duration>12:50</itunes:duration>
<itunes:keywords/>
</item>
<item>
<title>Summary of the October 1 Issue of JNCI</title>

<itunes:author>Oxford University Press</itunes:author>
<description><![CDATA[The October 1 issue of JNCI features articles on modeling breast cancer incidence in China, hormone therapy use and BRCA1 mutation carriers, increased mortality risks among childhood cancer survivors, predicting outcomes with posttreatment characteristics of ER+ breast cancer, a genetically altered bacterium for oncopathic therapy in pancreatic cancer, and Aurora Kinase A gene copy number and bladder cancer detection.]]></description>
<enclosure url="http://www.oxfordjournals.org/podcasts/jnci_100.19.mp3" length="12054528" type="audio/mpeg"/>
<guid>http://www.oxfordjournals.org/podcasts/jnci_100.19.mp3</guid>
<pubDate>Tue, 30 Sep 2008 10:00:00 GMT</pubDate>
<itunes:duration>08:22</itunes:duration>
<itunes:keywords/>
</item>
<item>
<title>Summary of the September 16 Issue of JNCI</title>
<itunes:author>Oxford University Press</itunes:author>

<description><![CDATA[The September 16 issue features articles on the cost-effectiveness of breast cancer screening in India, survival among US children with hematologic malignancies, compliance with nodal evaluation recommendations for colon cancer patients, an examination of bias in familial cancer risk estimates for common cancers, a summary of an NCI summit on gastroenteropancreatic neuroendocrine tumors, and an analysis of sequence variants at chromosome region 15q and the risk of familial lung cancer.]]></description>
<enclosure url="http://www.oxfordjournals.org/podcasts/jnci_100.18.mp3" length="14002513" type="audio/mpeg"/>
<guid>http://www.oxfordjournals.org/podcasts/jnci_100.18.mp3</guid>
<pubDate>Tue, 16 Sep 2008 10:00:00 GMT</pubDate>
<itunes:duration>09:43</itunes:duration>
<itunes:keywords/>
</item>
<item>
<title>Cancer-Related Fatigue</title>
<itunes:author>Oxford University Press</itunes:author>
<description><![CDATA[Dr. Patricia Ganz discusses possible treatments and mechanisms for cancer-related fatigue.]]></description>
<enclosure url="http://www.oxfordjournals.org/podcasts/jnci_100.17.interview.mp3" length="16507524" type="audio/mpeg"/>

<guid>http://www.oxfordjournals.org/podcasts/jnci_100.17.interview.mp3</guid>
<pubDate>Tue, 02 Sep 2008 10:00:00 GMT</pubDate>
<itunes:duration>11:27</itunes:duration>
<itunes:keywords/>
</item>
<item>
<title>Summary of the September 2 Issue of JNCI</title>
<itunes:author>Oxford University Press</itunes:author>
<description><![CDATA[The September 2 issue of JNCI features articles on nonmelanoma skin cancer and the risk for subsequent cancers, antihypertensive agents and chemoprevention of skin cancer, a potential anticancer drug from sea sponges, a mouse model for leukemia pathogenesis, and renal cell carcinoma risk associated with a mutation in a gene encoding a mitochondrial enzyme.]]></description>
<enclosure url="http://www.oxfordjournals.org/podcasts/jnci_100.17.mp3" length="10968145" type="audio/mpeg"/>
<guid>http://www.oxfordjournals.org/podcasts/jnci_100.17.mp3</guid>

<pubDate>Tue, 02 Sep 2008 10:00:00 GMT</pubDate>
<itunes:duration>07:36</itunes:duration>
<itunes:keywords/>
</item>
<item>
<title>Summary of the August 19 Issue of JNCI</title>
<itunes:author>Oxford University Press</itunes:author>
<description><![CDATA[The August 19 issue of JNCI features articles on hepatitis B virus genotypes and the risk of liver cancer, extended follow-up data for a prostate cancer trial, data on breast cancer recurrence after adjuvant therapy, possible treatments for cancer-related fatigue, antitumor effects of doxorubicin followed by zoledronic acid, and the incidence of adenocarcinoma of the esophagus among white Americans.]]></description>
<enclosure url="http://www.oxfordjournals.org/podcasts/jnci_100.16.mp3" length="6639616" type="audio/mpeg"/>
<guid>http://www.oxfordjournals.org/podcasts/jnci_100.16.mp3</guid>
<pubDate>Tue, 19 Aug 2008 10:00:00 GMT</pubDate>

<itunes:duration>09:12</itunes:duration>
<itunes:keywords/>
</item>
<item>
<title>Tomatoes and Cancer</title>
<itunes:author>Oxford University Press</itunes:author>
<description><![CDATA[Dr. Paul Coates discusses the FDAs review of evidence linking tomatoes, lycopene, and cancer risk.]]></description>
<enclosure url="http://www.oxfordjournals.org/podcasts/jnci_100.15.interview.mp3" length="12186386" type="audio/mpeg"/>
<guid>http://www.oxfordjournals.org/podcasts/jnci_100.15.interview.mp3</guid>
<pubDate>Tue, 05 Aug 2008 10:00:00 GMT</pubDate>
<itunes:duration>08:16</itunes:duration>

<itunes:keywords/>
</item>
<item>
<title>Summary of the August 5 Issue of JNCI</title>
<itunes:author>Oxford University Press</itunes:author>
<description><![CDATA[The August 5 issue of JNCI features articles on epirubicin dosage and the risk of cardiotoxicity, smoking among adult survivors of childhood cancer, a comparison of screening mammography in Norway and Vermont, a study of lapatinib for the prevention of breast cancer metastasis to the brain, mitochondrial DNA heritability and the association with renal cell carcinoma, and the inhibition of tumor growth using salmonella expressing Fas ligand.]]></description>
<enclosure url="http://www.oxfordjournals.org/podcasts/jnci_100.15.mp3" length="12186386" type="audio/mpeg"/>
<guid>http://www.oxfordjournals.org/podcasts/jnci_100.15.mp3</guid>
<pubDate>Tue, 05 Aug 2008 10:00:00 GMT</pubDate>
<itunes:duration>08:27</itunes:duration>
<itunes:keywords/>
</item>

<item>
<title>Summary of the July 16 Issue of JNCI</title>
<itunes:author>Oxford University Press</itunes:author>
<description><![CDATA[The July 16 issue of JNCI features articles on false-positive results in cancer epidemiology, adding SNPs to models of breast cancer risk, and reducing iron levels in the blood to reduce cancer risk. Also in the Journal are studies examining education level and cancer mortality, Medicare managed care after a cancer diagnosis, and a cell cycle regulator in prostate cancer invasion and metastasis.]]></description>
<enclosure url="http://www.oxfordjournals.org/podcasts/jnci_100.14.mp3" length="12549252" type="audio/mpeg"/>
<guid>http://www.oxfordjournals.org/podcasts/jnci_100.14.mp3</guid>
<pubDate>Tue, 15 Jul 2008 10:00:00 GMT</pubDate>
<itunes:duration>08:42</itunes:duration>
<itunes:keywords/>
</item>

<item>

<title>Summary of the July 1 issue of JNCI</title>
<itunes:author>Oxford University Press</itunes:author>
<description><![CDATA[ The July 1 issue feature articles on drug resistance in leukemia patients, a possible tumor suppressor gene for neuroblastoma, and the role of guanylyl cyclase C in colon cancer. Also in this issue are a study that suggests that regions of chromosome 8 are associated with several types of cancers, the relationship between NSAID use and melanoma risk, and a look at the criteria used to evaluate large epidemiologic studies.]]></description>
<enclosure url="http://www.oxfordjournals.org/podcasts/jnci_100.13.mp3" length="11437005" type="audio/mpeg"/>
<guid>http://www.oxfordjournals.org/podcasts/jnci_100.13.mp3</guid>
<pubDate>Tue, 01 Jul 2008 10:00:00 GMT</pubDate>
<itunes:duration>07:56</itunes:duration>
<itunes:keywords/>
</item>
<item>
<title>Summary of the June 17 issue of JNCI</title>

<itunes:author>Oxford University Press</itunes:author>
<description><![CDATA[ The June 17 issue of JNCI features articles on the accuracy of screening mammography in relation to mammography facility characteristics, a new analysis of the RUTH trial, and targeting NF-kappa B to treat melanoma. Also in the Journal are charts for determining one's risk of death by age, sex, and smoking history, an analysis of trends in the cost of initial cancer treatment, and a study on melatonin and breast cancer risk in postmenopausal women. ]]></description>
<enclosure url="http://www.oxfordjournals.org/podcasts/jnci_100.12.mp3" length="12811908" type="audio/mpeg"/>
<guid>http://www.oxfordjournals.org/podcasts/jnci_100.12.mp3</guid>
<pubDate>Tue, 17 Jun 2008 16:00:00 GMT</pubDate>
<itunes:duration>08:53</itunes:duration>
<itunes:keywords/>
</item>
<item>
<title>Summary of the June 3 issue of JNCI</title>
<itunes:author>Oxford University Press</itunes:author>

<description><![CDATA[ The June 3 issue of JNCI features articles on antioxidant supplementation during radiation therapy or chemotherapy, the role of overlapping tumor suppressors in melanoma, and the relationship between vitamin D levels in the blood and the risk of prostate cancer. Also in the Journal are a randomized trial on the addition of taxanes to standard adjuvant chemotherapy for women with lymph node-positive breast cancer and a study of estrogen-dependent signaling in an aggressive form of prostate cancer. ]]></description>
<enclosure url="http://www.oxfordjournals.org/podcasts/jnci_100.11.mp3" length="10922061" type="audio/mpeg"/>
<guid>http://www.oxfordjournals.org/podcasts/jnci_100.11.mp3</guid>
<pubDate>Tue, 03 Jun 2008 16:00:00 GMT</pubDate>
<itunes:duration>08:11</itunes:duration>
<itunes:keywords/>
</item>
<item>
<title>Summary of the May 20 issue of JNCI</title>
<itunes:author>Oxford University Press</itunes:author>
<description><![CDATA[ Issue 10 of the Journal features articles on using 18F-FDG PET to detect cervical node metastases in head and neck cancer patients, improved designs for liver cancer trials, the breast cancer risk in sisters of women with the disease, the association between exercise and premenopausal breast cancer, treatment disparities among rectal cancer patients after referral to oncologist, and the lack of a causal association between sphincterotomy and cholangiocarcinoma. ]]></description>
<enclosure url="http://www.oxfordjournals.org/podcasts/jnci_100.10.mp3" length="11789965" type="audio/mpeg"/>

<guid>http://www.oxfordjournals.org/podcasts/jnci_100.10.mp3</guid>
<pubDate>Tue, 20 May 2008 11:00:00 GMT</pubDate>
<itunes:duration>08:11</itunes:duration>
<itunes:keywords/>
</item>
<item>
<title>Summary of the May 6 issue of JNCI</title>
<itunes:author>Oxford University Press</itunes:author>
<itunes:subtitle>Volume 100, Issue 9 of the Journal of the National Cancer Institute
</itunes:subtitle>
<itunes:summary/>
<enclosure url="http://www.oxfordjournals.org/podcasts/jnci_episode16.mp3" length="1234380" type="audio/mpeg"/>

<guid>http://www.oxfordjournals.org/podcasts/jnci_episode16.mp3</guid>
<pubDate>Tue, 06 May 2008 11:00:00 GMT</pubDate>
<itunes:duration>08:34</itunes:duration>
<itunes:keywords/>
</item>
<item>
<title>Summary of the April 15 issue of JNCI</title>
<itunes:author>Oxford University Press</itunes:author>
<itunes:subtitle>Volume 100, Issue 8 of the Journal of the National Cancer Institute
</itunes:subtitle>
<itunes:summary/>
<enclosure url="http://www.oxfordjournals.org/podcasts/jnci_episode15.mp3" length="12410880" type="audio/mpeg"/>

<guid>http://www.oxfordjournals.org/podcasts/jnci_episode15.mp3</guid>
<pubDate>Tue, 15 Apr 2008 10:00:00 GMT</pubDate>
<itunes:duration>08:36</itunes:duration>
<itunes:keywords/>
</item>

<item>
<title>Summary of the April 1 issue of JNCI</title>
<itunes:author>Oxford University Press</itunes:author>
<itunes:subtitle>Volume 100, Issue 7 of the Journal of the National Cancer Institute
</itunes:subtitle>
<itunes:summary/>

<enclosure url="http://www.oxfordjournals.org/podcasts/jnci_episode14.mp3" length="12189696" type="audio/mpeg"/>
<guid>http://www.oxfordjournals.org/podcasts/jnci_episode14.mp3</guid>
<pubDate>Tue, 1 Apr 2008 10:00:00 GMT</pubDate>
<itunes:duration>08:27</itunes:duration>
<itunes:keywords/>
</item>
<item>
<title>Summary of the March 18 issue of JNCI</title>
<itunes:author>Oxford University Press</itunes:author>
<itunes:subtitle>Volume 100, Issue 6 of the Journal of the National Cancer Institute
</itunes:subtitle>
<itunes:summary/>

<enclosure url="http://www.oxfordjournals.org/podcasts/jnci_episode13.mp3" length="12623872" type="audio/mpeg"/>
<guid>http://www.oxfordjournals.org/podcasts/jnci_episode13.mp3</guid>
<pubDate>Tue, 18 Mar 2008 12:00:00 GMT</pubDate>
<itunes:duration>08:45</itunes:duration>
<itunes:keywords/>
</item>
<item>
<title>Summary of the March 4 issue of JNCI</title>
<itunes:author>Oxford University Press</itunes:author>
<itunes:subtitle>Issue 5 features articles on radiation therapy dosage, the economic burden of breast cancer, the cost-effectiveness of cervical cancer screening, interventions to increase mammography screening, and interleukin-8 as a potential target for ovarian cancer
</itunes:subtitle>
<itunes:summary/>

<enclosure url="http://www.oxfordjournals.org/podcasts/jnci_episode12.mp3" length="1147840" type="audio/mpeg"/>
<guid>http://www.oxfordjournals.org/podcasts/jnci_episode12.mp3</guid>
<pubDate>Tue, 04 Mar 2008 12:00:00 GMT</pubDate>
<itunes:duration>07:55</itunes:duration>
<itunes:keywords/>
</item>
<item>
<title>Summary of the February 19 Issue of JNCI</title>
<itunes:author>Oxford University Press</itunes:author>
<itunes:subtitle>Summary of Volume 100, Issue 4 of JNCI
</itunes:subtitle>
<itunes:summary/>

<enclosure url="http://www.oxfordjournals.org/podcasts/jnci_episode11.mp3" length="11993088" type="audio/mpeg"/>
<guid>http://www.oxfordjournals.org/podcasts/jnci_episode11.mp3</guid>
<pubDate>Tue, 19 Feb 2008 12:00:00 GMT</pubDate>
<itunes:duration>08:19</itunes:duration>
<itunes:keywords/>
</item>
<item>
<title>Summary of the February 5 Issue of JNCI </title>
<itunes:author>Oxford University Press</itunes:author>
<itunes:subtitle>Issue 3 of the Journal features articles on sorafenib's potential for  treating some leukemias, sex hormones and prostate cancer risk, the Impact of surgeon characteristics on cancer care, a protein associated with breast cancer prognosis.
</itunes:subtitle>
<itunes:summary/>

<enclosure url="http://www.oxfordjournals.org/podcasts/jnci_episode10.mp3" length="11389189" type="audio/mpeg"/>
<guid>http://www.oxfordjournals.org/podcasts/jnci_episode10.mp3</guid>
<pubDate>Tue, 05 Feb 2008 10:56:00 GMT</pubDate>
<itunes:duration>07:54</itunes:duration>
<itunes:keywords/>
</item>
<item>
<title>Statins and cancer prevention from Charles White</title>
<itunes:author>Oxford University Press</itunes:author>
<itunes:subtitle>Dr. White talks about the conflicting findings in statin clinical trials and their uncertain role in cancer prevention.</itunes:subtitle>
<itunes:summary/>

<enclosure url="http://www.oxfordjournals.org/podcasts/jnci_episode9.mp3" length="19562496" type="audio/mpeg"/>
<guid>http://www.oxfordjournals.org/podcasts/jnci_episode9.mp3</guid>
<pubDate>Tue, 15 Jan 2008 10:30:00 GMT</pubDate>
<itunes:duration>13:34</itunes:duration>
<itunes:keywords/>
</item>
<item>
<title>Dan Hayes interview on HER2 status and anthracyclines</title>
<itunes:author>Oxford University Press</itunes:author>
<itunes:subtitle>Dr. Hayes talks about how breast cancer patients' HER2 status may change how doctors decide what type of chemotherapy they will receive.</itunes:subtitle>
<itunes:summary/>

<enclosure url="http://www.oxfordjournals.org/podcasts/jnci_episode8.mp3" length="19160026" type="audio/mpeg"/>
<guid>http://www.oxfordjournals.org/podcasts/jnci_episode8.mp3</guid>
<pubDate>Wed, 02 Jan 2008 10:30:00 GMT</pubDate>
<itunes:duration>13:18</itunes:duration>
<itunes:keywords/>
</item>
<item>
<title>Joann Elmore interview on radiologists role in mammography quality</title>
<itunes:author>Oxford University Press</itunes:author>
<itunes:subtitle>Dr. Elmore talks about the wide variation in radiologists performance and how that might impact the quality of diagnostic mammograms.</itunes:subtitle>
<itunes:summary/>

<enclosure url="http://www.oxfordjournals.org/podcasts/jnci_episode7.mp3" length="1966350" type="audio/mpeg"/>
<guid>http://www.oxfordjournals.org/podcasts/jnci_episode7.mp3</guid>
<pubDate>Tue, 11 Dec 2007 11:30:00 GMT</pubDate>
<itunes:duration>13:18</itunes:duration>
<itunes:keywords/>
</item>
<item>
<title>Mitchell Gail interview on a new breast cancer risk model for African American women</title>
<itunes:author>Oxford University Press</itunes:author>
<itunes:subtitle>Dr. Gail discusses the need for a new model to estimate breast cancer risk in African American women and how the model might be used in cancer prevention.</itunes:subtitle>
<itunes:summary/>

<enclosure url="http://www.oxfordjournals.org/podcasts/jnci_episode6.mp3" length="17625008" type="audio/mpeg"/>
<guid>http://www.oxfordjournals.org/podcasts/jnci_episode6.mp3</guid>
<pubDate>Tue, 04 Dec 2007 11:30:00 GMT</pubDate>
<itunes:duration>12:14</itunes:duration>
<itunes:keywords/>
</item>
<item>
<title>David Spiegel interview on hypnosis and pain</title>
<itunes:author>Oxford University Press</itunes:author>
<itunes:subtitle>Dr. David Spiegel discusses the surprising success of hypnosis in treating surgical pain.</itunes:subtitle>
<itunes:summary/>

<enclosure url="http://www.oxfordjournals.org/podcasts/jnci_episode5.mp3" length="14161993" type="audio/mpeg"/>
<guid>http://www.oxfordjournals.org/podcasts/jnci_episode5.mp3</guid>
<pubDate>Tue, 20 Nov 2007 16:00:00 GMT</pubDate>
<itunes:duration>09:49</itunes:duration>
<itunes:keywords/>
</item>
<item>
<title>Mary Relling interview on newly discovered genome complexity</title>
<itunes:author>Oxford University Press</itunes:author>
<itunes:subtitle>Dr. Relling discusses newly uncovered functions in the area between genes and how they may make personalized medicine more complex.</itunes:subtitle>

<itunes:summary/>
<enclosure url="http://www.oxfordjournals.org/podcasts/jnci_episode4.mp3" length="19865037" type="audio/mpeg"/>
<guid>http://www.oxfordjournals.org/podcasts/jnci_episode4.mp3</guid>
<pubDate>Tue, 06 Nov 2007 13:00:00 GMT</pubDate>
<itunes:duration>13:48</itunes:duration>
<itunes:keywords/>
</item>
<item>
<title>Ruth Etzioni interview on the problems with PSA velocity</title>
<itunes:author>Oxford University Press</itunes:author>
<itunes:subtitle>Dr. Etizoni discusses how using PSA velocity for cancer screening may lead to misinterpretation.</itunes:subtitle>

<itunes:summary/>
<enclosure url="http://www.oxfordjournals.org/podcasts/jnci_episode3.mp3" length="16067344" type="audio/mpeg"/>
<guid>http://www.oxfordjournals.org/podcasts/jnci_episode3.mp3</guid>
<pubDate>Tue, 16 Oct 2007 16:00:00 GMT</pubDate>
<itunes:duration>11:09</itunes:duration>
<itunes:keywords/>
</item>
<item>
<title>Ian Tannock interview on drug resistance and the tumor microenvironment</title>
<itunes:author>Oxford University Press</itunes:author>
<itunes:subtitle>Ian Tannock discusses how the tumor microenvironment contributes to drug resistance.</itunes:subtitle>

<itunes:summary/>
<enclosure url="http://www.oxfordjournals.org/podcasts/jnci_episode2.mp3" length="22992408" type="audio/mpeg"/>
<guid>http://www.oxfordjournals.org/podcasts/jnci_episode2.mp3</guid>
<pubDate>Mon, 08 Oct 2007 16:00:00 GMT</pubDate>
<itunes:duration>11:59</itunes:duration>
<itunes:keywords/>
</item>
<item>
<title>Paul Schellhammer interview on finasteride and prostate cancer</title>
<itunes:author>Oxford University Press</itunes:author>
<itunes:subtitle>Dr. Paul Schelhammer talks about finasteride and its use in prostate cancer prevention.</itunes:subtitle>

<itunes:summary/>
<enclosure url="http://www.oxfordjournals.org/podcasts/jnci_episode1.mp3" length="12026144" type="audio/mpeg"/>
<guid>http://www.oxfordjournals.org/podcasts/jnci_episode1.mp3</guid>
<pubDate>Tue, 18 Sep 2007 16:00:00 GMT</pubDate>
<itunes:duration>12:32</itunes:duration>
<itunes:keywords/>
</item>
</channel>
</rss>

